Total (N = 266) | AD (n = 131) | ED (n = 135) | p-value | |
---|---|---|---|---|
Sex, Women n (%) | 239 (89.85) | 114 (87.02) | 125 (92.59) | .133 |
Age, year | ||||
M (SD) | 44.55 (9.29) | 42.97 (9.77) | 46.09 (8.59) | .006 |
Minimum—maximum | 25–66 | 25–66 | 25–63 | |
Highest education, n (%) | .002 | |||
College/university, ≥ 3 years | 178 (67) | 101 (77) | 77 (57) | .001 |
College/university, < 3 years | 46 (17) | 15 (11) | 31 (23) | .013 |
Secondary school, 2–3 years | 42 (15.79) | 15 (11) | 27 (20) | .056 |
Employment status, n (%) | < .001 | |||
Full time | 144 (54.14) | 98 (74.81) | 46 (34.07) | < .001 |
Part time (25—90%) | 63 (23.68) | 19 (14.5) | 44 (32.59) | .001 |
Othera | 49 (18) | 12 (9) | 37 (27) | < .001 |
Unemployed | 10 (3.76) | 2 (1.53) | 8 (5.93) | .059 |
Sick leave, n (%) | 57 (21.43) | 4 (3.05) | 53 (39.26) | < .001 |
Self-reported symptom duration (years) | ||||
M (SD) | 2.19 (1.89) | 1.85 (1.83) | 2.52 (1.9) | .004 |
Median | 1.67 | 1.33 | 2 | |
Minimum—maximum | .25–10 | .25–10 | .25–10 | |
Comorbid psychiatric diagnosis n (%) | 62 (37.78) | 11 (8.4) | 51 (23.31) | < .001 |
Anxiety disorders | 25 (9.4) | 6 (4.58) | 19 (14.07) | .015 |
Depression | 28 (10.53) | 3 (2.29) | 25 (18.52) | < .001 |
Otherb | 9 (3.38) | 2 (1.53) | 7 (5.19) | .19 |
Self-reported neuropsychiatric disorders | 17 (6.39) | 6 (4.58) | 11 (8.15) | .348 |
Medication, n (%) | 120 (45) | 36 (27) | 84 (62) | < .001 |
Anxiolytics | 14 (5.26) | 4 (3.05) | 10 (7.41) | .112 |
Sleeping medication | 49 (18.42) | 16 (12.21) | 33 (24.44) | .01 |
Antidepressants | 53 (19.92) | 16 (12.21) | 37 (27.41) | .002 |
Pain medication | 4 (1.5) | 0 (0) | 4 (2.96) | .139 |
Swedish native speaker, n (%) | 245 (92.11) | 117 (89.31) | 128 (94.81) | .096 |
6-QEMP | ||||
M (SD) | 14.65 (3.95) | 12.95 (3.53) | 16.3 (3.65) | < .001 |
Minimum—maximum | 5—24 | 5—22 | 8—24 | |
SMBQ-18 | ||||
M (SD) | 5.21 (0.89) | 4.82 (.84) | 5.58 (.79) | < .001 |
Minimum—maximum | 2—7 | 2—6.56 | 3.5—7 |